SR

Seth Rudnick

Partner at Canaan Partners

Norwalk, Connecticut

VC
Investor

Invests in

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Skills

Corporate Development
Due Diligence
Lifesciences
Venture Capital
Biotechnology
R&D
Start-ups
Technology Transfer
Entrepreneurship
Commercialization
Product Development
Angel Investing
Venture Financing
Mergers & Acquisitions
Drug Development
Life Sciences
Strategy

Education

Investments

VaxInnate

Series C

Total Funding: $70M

CombinatoRx

Series C

Total Funding: $30M

Amicas

Post Ipo Equity

Total Funding: $9M

Work Experience

Liquidia Technologies

2008

  • Chairman

    2008

CP
Canaan Partners

1998 - 2013

  • Retired Partner

    1998 - 2013

Cytotherapeutics

1991 - 1998

  • CEO and Chairman

    1991 - 1998

OB
Ortho Biotech

1986 - 1991

  • Executive VP R&D

    1986 - 1991

Biogen, Inc.

1981 - 1986

  • Senior Vice President Pharmaceutical Development

    1981 - 1986